Suppr超能文献

相似文献

1
Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1.
Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):1188-93. doi: 10.1073/pnas.98.3.1188. Epub 2001 Jan 23.
2
Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.
Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):13125-30. doi: 10.1073/pnas.202480499. Epub 2002 Sep 13.
3
NQO1 stabilizes p53 through a distinct pathway.
Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3099-104. doi: 10.1073/pnas.052706799. Epub 2002 Feb 26.
4
P53 hot-spot mutants are resistant to ubiquitin-independent degradation by increased binding to NAD(P)H:quinone oxidoreductase 1.
Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15065-70. doi: 10.1073/pnas.2436329100. Epub 2003 Nov 21.
5
NAD(P)H:Quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity.
J Biol Chem. 2000 Feb 25;275(8):5416-24. doi: 10.1074/jbc.275.8.5416.
6
Inhibition of NAD(P)H:quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin.
Proc Natl Acad Sci U S A. 2005 Apr 12;102(15):5535-40. doi: 10.1073/pnas.0501828102. Epub 2005 Apr 4.
9
Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells.
World J Gastroenterol. 2010 May 21;16(19):2362-70. doi: 10.3748/wjg.v16.i19.2362.

引用本文的文献

2
Angiosarcoma: a systematic review of biomarkers in diagnosis, prognosis, and therapeutic strategies.
Front Oncol. 2025 Jul 1;15:1623327. doi: 10.3389/fonc.2025.1623327. eCollection 2025.
3
Computational modelling identifies primary mediators of crosstalk between DNA damage and oxidative stress responses.
PLoS Comput Biol. 2025 Mar 10;21(3):e1012844. doi: 10.1371/journal.pcbi.1012844. eCollection 2025 Mar.
4
Human NQO1 as a Selective Target for Anticancer Therapeutics and Tumor Imaging.
Cells. 2024 Jul 29;13(15):1272. doi: 10.3390/cells13151272.
5
Riboflavin compounds show NAD(P)H dependent quinone oxidoreductase-like quinone reducing activity.
J Clin Biochem Nutr. 2023 Jul;73(1):52-60. doi: 10.3164/jcbn.22-140. Epub 2023 May 16.
7
Association of p53 with Neurodegeneration in Parkinson's Disease.
Parkinsons Dis. 2022 May 11;2022:6600944. doi: 10.1155/2022/6600944. eCollection 2022.
9
Review on NAD(P)H dehydrogenase quinone 1 (NQO1) pathway.
Mol Biol Rep. 2022 Sep;49(9):8907-8924. doi: 10.1007/s11033-022-07369-2. Epub 2022 Mar 28.
10
NRF2 and Key Transcriptional Targets in Melanoma Redox Manipulation.
Cancers (Basel). 2022 Mar 16;14(6):1531. doi: 10.3390/cancers14061531.

本文引用的文献

1
Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity.
J Biol Chem. 2001 Feb 2;276(5):3361-70. doi: 10.1074/jbc.M007140200. Epub 2000 Oct 31.
2
Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF.
Cell. 2000 Oct 13;103(2):321-30. doi: 10.1016/s0092-8674(00)00123-9.
4
The Werner syndrome protein contributes to induction of p53 by DNA damage.
FASEB J. 2000 Nov;14(14):2138-40. doi: 10.1096/fj.00-0171fje.
5
Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae.
Science. 2000 Sep 22;289(5487):2126-8. doi: 10.1126/science.289.5487.2126.
6
Role of NAD(P)H:quinone oxidoreductase 1 (DT diaphorase) in protection against quinone toxicity.
Biochem Pharmacol. 2000 Jul 15;60(2):207-14. doi: 10.1016/s0006-2952(00)00321-x.
8
DNA damage-induced activation of p53 by the checkpoint kinase Chk2.
Science. 2000 Mar 10;287(5459):1824-7. doi: 10.1126/science.287.5459.1824.
9
10
NAD(P)H:Quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity.
J Biol Chem. 2000 Feb 25;275(8):5416-24. doi: 10.1074/jbc.275.8.5416.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验